These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 21295398)

  • 41. New therapeutic developments in renal cell cancer.
    Prenen H; Gil T; Awada A
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):56-63. PubMed ID: 18752971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Editorial comment to therapy management of cardiovascular adverse events in the context of targeted therapy for metastatic renal cell carcinoma.
    Ravaud A
    Int J Urol; 2012 Sep; 19(9):805. PubMed ID: 22651229
    [No Abstract]   [Full Text] [Related]  

  • 43. Advanced renal cell carcinoma in Australia, 2015: what should we do?
    Davis ID
    Asia Pac J Clin Oncol; 2014 Dec; 10(4):285-8. PubMed ID: 25392943
    [No Abstract]   [Full Text] [Related]  

  • 44. Coronary vasospasm after interferon administration.
    Yamamoto N; Nishigaki K; Ban Y; Kawada Y
    Br J Urol; 1998 Jun; 81(6):916-7. PubMed ID: 9666784
    [No Abstract]   [Full Text] [Related]  

  • 45. Hypertension in cancer patients.
    Mouhayar E; Salahudeen A
    Tex Heart Inst J; 2011; 38(3):263-5. PubMed ID: 21720467
    [No Abstract]   [Full Text] [Related]  

  • 46. Molecular subtyping of metastatic renal cell carcinoma: implications for targeted therapy.
    Wang L; Williamson SR; Wang M; Davidson DD; Zhang S; Baldridge LA; Du X; Cheng L
    Mol Cancer; 2014 Feb; 13():39. PubMed ID: 24568263
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toxicities of targeted therapy and their management in kidney cancer.
    Di Lorenzo G; Porta C; Bellmunt J; Sternberg C; Kirkali Z; Staehler M; Joniau S; Montorsi F; Buonerba C
    Eur Urol; 2011 Apr; 59(4):526-40. PubMed ID: 21277078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is tumor response important for renal carcinoma?
    Inman BA; George DJ
    Eur Urol; 2011 Jan; 59(1):16-7. PubMed ID: 20970245
    [No Abstract]   [Full Text] [Related]  

  • 49. Review: therapy for kidney cancer with a sarcomatoid component.
    Fishman M
    Clin Adv Hematol Oncol; 2011 Jan; 9(1):67-9. PubMed ID: 21326150
    [No Abstract]   [Full Text] [Related]  

  • 50. Noninfectious pneumonitis in a patient with renal cell carcinoma treated with everolimus.
    Creel P; Moldawer NP
    Oncol Nurs Forum; 2011 Mar; 38(2):125-8. PubMed ID: 21356651
    [No Abstract]   [Full Text] [Related]  

  • 51. The dark side of targeted therapy.
    Karam JA; Wood CG
    Eur Urol; 2011 Apr; 59(4):541-2. PubMed ID: 21295398
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.